Taimei Technology
Jiaxing
About Taimei Technology
Taimei Technology is a Digital Innovator in the R&D and Life Science Industry. Taimei has developed an industry-leading, successfully deployed integrated digital platform that is dedicated to clinical research with in-depth insights into drug R&D, pharmacovigilance, marketing & sales and market access. Our unified digital platform integrates advanced AI, big data, cloud computing and mobile Internet technologies to provide innovative solutions to the industry stakeholders across the full product life cycle. Taimei Technology is building the infrastructure for the future of the life science industry to accelerate product launches, improve quality, enhance drug safety, improve drug accessibility and reduce the medical burden on patients and providers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 501 – 1,000
- Estimated revenue: $50K – $100K
- Total funding: $530.3M
- Funding stage: IPO
- Last round: Series Unknown (Sep 2020)
- Ticker: hkg:2576.HK
- Website: taimei.com
- Phone: +86 021-68825798
Industries & Categories
Biopharma, Biotechnology, Clinical Trials, Cloud Computing, Medical
Social Profiles
Canonical: https://fsome.com/organization/taimei-technology-7244 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.